What Know About This Fund's $65 Million Homebuilder Bet Before a $47-Per-Share Buyout
A major fund plowed into a top U.S. homebuilder with a $65 million stake, ahead of a rumored $47-per-share buyout. He...
Making the most of retirement involves embracing new experiences and opportunities. Uncover ways to enhance your retirement life.
19,695 articlesA major fund plowed into a top U.S. homebuilder with a $65 million stake, ahead of a rumored $47-per-share buyout. He...
Investors and policymakers are weighing a potential framework to end decades-long Iran tensions and reopen the Strait...
Johnson & Johnson and AbbVie report strong Q1 2026 results, showcasing two contrasting growth paths as biosimilar cha...
With signs that the Iran conflict is cooling, markets eye how oil, spreads, and Central Bank policy could reshape mor...
Stocks climbed as heavyweight tech names posted solid results and ceasefire hopes supported risk appetite, sending th...
March data from the Case-Shiller indices confirms a slower pace of home price growth, signaling ongoing cooling acros...
Investors are weighing two very different quantum paths. This guide compares D-Wave Quantum and IonQ, highlighting te...
Ethereum flirts with a critical level as it trades around the $2,100 mark. A breakdown of $1,800 could accelerate los...
Marvell Technology is set to report fiscal Q1 results after the close, with investors weighing AI demand, margins and...
Insider trades by top executives can shape market perception. This guide explains what a chief medical officer sells ...
Malin Akerman and husband Jack Donnelly have put their Hollywood Hills retreat on the market for around $3 million. T...
Two affordable biotech names are drawing attention for potential low-beta growth as AI-driven tools reshape pipelines...